CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 72 filers reported holding CULLINAN ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,169,511 | +6.6% | 239,725 | +26.8% | 0.00% | 0.0% |
| Q2 2023 | $2,034,425 | +81212.0% | 189,073 | -22.7% | 0.00% | 0.0% |
| Q1 2023 | $2,502 | +10.7% | 244,553 | +14.1% | 0.00% | 0.0% |
| Q4 2022 | $2,261 | -99.9% | 214,269 | +43.4% | 0.00% | 0.0% |
| Q3 2022 | $1,915,000 | -53.6% | 149,407 | -53.6% | 0.00% | -66.7% |
| Q2 2022 | $4,124,000 | +3649.1% | 321,684 | +2959.3% | 0.00% | – |
| Q1 2022 | $110,000 | -97.6% | 10,515 | -94.9% | 0.00% | -100.0% |
| Q3 2021 | $4,673,000 | -22.3% | 207,030 | -11.4% | 0.00% | -25.0% |
| Q2 2021 | $6,017,000 | -64.2% | 233,661 | -42.1% | 0.00% | -66.7% |
| Q1 2021 | $16,828,000 | – | 403,836 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |